Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Clinterooon Feb 21, 2013 8:04pm

126 Views

Post# 21026052

RE: RE: RE: Cash down th Drain

Don't matter to me ! Just pointing to the obvious...!

No Cash.....no forward momentum.

You are hardly pointing out the obvious. No cash does not mean no froward momentum. Again, this is a speculative stock. It will move on news and speculation. Cash or no cash. I see your failed to answer any questions... as expected.

Bullboard Posts

Critical materials crisis: Diversifying away from China’s monopoly